TD Cowen analyst Shaul Eyal increased the price target on Fortinet stock (NASDAQ:FTNT) to $135 from the previous target of $120, while maintaining a Buy rating on the shares. The adjustment follows ...

Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Kornit Digital (KRNT – Research Report), with a ...

Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...

Cantor Fitzgerald analyst Brett Knoblauch reaffirmed an Overweight rating on Udemy Inc (NASDAQ:UDMY), with a steady price target of $11.00. This target aligns with broader market sentiment, as ...

Cantor Fitzgerald analyst C. Canfield expects that the company will earn ($1.10) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $30.00 target price on the ...

Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

The current valuation of ORIC Pharmaceuticals, according to Cantor Fitzgerald, does not fully account for its prostate cancer treatment potential. The analyst believes that the company's lung ...

As such, the insights provided by Cantor Fitzgerald analysts offer a glimpse into the company's strategic maneuvers in the face of industry challenges and opportunities. In other recent news ...